Terms: = Liver cancer AND MYD88, Q99836, MYD88D, 4615
66 results:
1. TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.
Mohamed FEZA; Dewidar B; Lin T; Ebert MP; Dooley S; Meindl-Beinker NM; Hammad S
Int J Exp Pathol; 2024 Apr; 105(2):64-74. PubMed ID: 38328944
[TBL] [Abstract] [Full Text] [Related]
2. myd88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
[TBL] [Abstract] [Full Text] [Related]
3. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.
Wang J; Zhang X; Ma X; Chen D; Cai M; Xiao L; Li J; Huang Z; Huang Y; Lian Y
J Exp Clin Cancer Res; 2023 Nov; 42(1):303. PubMed ID: 37968706
[TBL] [Abstract] [Full Text] [Related]
4. Structural characteristics of a novel Bletilla striata polysaccharide and its activities for the alleviation of liver fibrosis.
Jiang G; Wang B; Wang Y; Kong H; Wang Y; Gao P; Guo M; Li W; Zhang J; Wang Z; Niu J
Carbohydr Polym; 2023 Aug; 313():120781. PubMed ID: 37182941
[TBL] [Abstract] [Full Text] [Related]
5. PathwayKO: An integrated platform for deciphering the systems-level signaling pathways.
Ai H; Meng F; Ai Y
Front Immunol; 2023; 14():1103392. PubMed ID: 37033947
[TBL] [Abstract] [Full Text] [Related]
6. Role of targeting TLR4 signaling axis in liver-related diseases.
Tang YL; Zhu L; Tao Y; Lu W; Cheng H
Pathol Res Pract; 2023 Apr; 244():154410. PubMed ID: 36917917
[TBL] [Abstract] [Full Text] [Related]
7. Long noncoding RNA myd88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract] [Full Text] [Related]
8. Small RNA sequencing and identification of Andrographis paniculata miRNAs with potential cross‑kingdom human gene targets.
Motwani H; Patel M; Nanavaty V; Dixit N; Rawal RM; Patel SK; Solanki HA
Funct Integr Genomics; 2023 Feb; 23(1):55. PubMed ID: 36725761
[TBL] [Abstract] [Full Text] [Related]
9. Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/myd88/IL6 axis.
Xiao F; Xu F; Zhang H; Shuai X
Biochem Biophys Res Commun; 2022 Apr; 600():101-108. PubMed ID: 35248826
[TBL] [Abstract] [Full Text] [Related]
10. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis.
Iida N; Mizukoshi E; Yamashita T; Yutani M; Seishima J; Wang Z; Arai K; Okada H; Yamashita T; Sakai Y; Masuo Y; Agustina R; Kato Y; Fujinaga Y; Oshima M; Honda M; Lebreton F; Gilmore MS; Kaneko S
Nat Cancer; 2021 Oct; 2(10):1039-1054. PubMed ID: 35121877
[TBL] [Abstract] [Full Text] [Related]
11.
Dai W; Zhan X; Peng W; Liu X; Peng W; Mei Q; Hu X
Oxid Med Cell Longev; 2021; 2021():2617881. PubMed ID: 34966476
[TBL] [Abstract] [Full Text] [Related]
12. Knockdown RBM15 Inhibits Colorectal cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of myd88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract] [Full Text] [Related]
13. CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
Wang G; Zhang X; Cheng W; Mo Y; Chen J; Cao Z; Chen X; Cui H; Liu S; Huang L; Liu M; Ma L; Ma NF
Cell Death Dis; 2021 Sep; 12(10):891. PubMed ID: 34588420
[TBL] [Abstract] [Full Text] [Related]
14. Role of the CXCR3‑mediated TLRs/myd88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer.
Yuan G; Chen B; Meng Y; Lu J; Shi X; Hu A; Hu Y; Wang D
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435646
[TBL] [Abstract] [Full Text] [Related]
15. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
Front Immunol; 2021; 12():684424. PubMed ID: 34113355
[TBL] [Abstract] [Full Text] [Related]
16. Commensal-driven immune zonation of the liver promotes host defence.
Gola A; Dorrington MG; Speranza E; Sala C; Shih RM; Radtke AJ; Wong HS; Baptista AP; Hernandez JM; Castellani G; Fraser IDC; Germain RN
Nature; 2021 Jan; 589(7840):131-136. PubMed ID: 33239787
[TBL] [Abstract] [Full Text] [Related]
17. [Over-expression of miR-144 inhibits invasion of liver cancer SMMC-7721 cells
Yi Q; Liu J; Alexia K; Li J; Luo H; Sun J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):765-771. PubMed ID: 32897198
[TBL] [Abstract] [Full Text] [Related]
18. The effect of dihydropyrazines on lipopolysaccharide-stimulated human hepatoma HepG2 cells via regulating the TLR4-myd88-mediated NF-κB signaling pathway.
Esaki M; Ishida T; Miyauchi Y; Takechi S
J Toxicol Sci; 2020; 45(7):401-409. PubMed ID: 32612008
[TBL] [Abstract] [Full Text] [Related]
19. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group.
Maqbool MG; Tam CS; Morison IM; Simpson D; Mollee P; Schneider H; Chan H; Juneja S; Harvey Y; Nath L; Hissaria P; Prince HM; Wordsworth H; Opat S; Talaulikar D
Pathology; 2020 Feb; 52(2):167-178. PubMed ID: 31902622
[TBL] [Abstract] [Full Text] [Related]
20. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
[TBL] [Abstract] [Full Text] [Related]
[Next]
